Filing Details
- Accession Number:
- 0001548538-17-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-26 11:57:01
- Reporting Period:
- 2017-05-24
- Filing Date:
- 2017-05-26
- Accepted Time:
- 2017-05-26 11:57:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1302573 | Oncomed Pharmaceuticals Inc | OMED | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1225480 | D Jonathan Root | 1460 El Camino Real Suite 100 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-05-24 | 2,853 | $3.72 | 6,358 | No | 4 | S | Indirect | Directly owned by EP VIII-A |
Common Stock | Disposition | 2017-05-24 | 1,447 | $3.72 | 3,222 | No | 4 | S | Indirect | Directly owned by EP VIII-B |
Common Stock | Disposition | 2017-05-26 | 6,358 | $3.70 | 0 | No | 4 | S | Indirect | Directly owned by EP VIII-A |
Common Stock | Disposition | 2017-05-26 | 3,222 | $3.70 | 0 | No | 4 | S | Indirect | Directly owned by EP VIII-B |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Directly owned by EP VIII-A |
No | 4 | S | Indirect | Directly owned by EP VIII-B |
No | 4 | S | Indirect | Directly owned by EP VIII-A |
No | 4 | S | Indirect | Directly owned by EP VIII-B |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 121,020 | Direct |
Footnotes
- Represents a weigthed average sales price of all trades for the day for the direct owner.
- The reported securities are owned directly by each of U.S. Venture Partners VIII, L.P. ("USVP VIII"), USVP VIII Affiliates Fund, L.P. ("AFF VIII"), USVP Entrepreneur Partners VIII-A, L.P. ("EP VIII-A") and USVP Entrepreneur Partners VIII-B, L.P. ("EP VIII-B" and together with USVP VIII, AFF VIII and EP VIII-A, the "USVP VIII Funds"). Presidio Management Group VIII, L.L.C. ("PMG VIII") is the general partner of each of USVP VIII, AFF VIII, EP VIII-A and EP VIII-B and may be deemed to have sole voting and dispositive power over the shares held by the USVP VIII Funds. PMG VIII and each of Irwin Federman, Steven M. Krausz, David Liddle, Jonathan D. Root, Casey M. Tansey and Philip M. Young, the managing members of PMG VIII who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the USVP VIII Funds except to the extent of any pecuniary interest therein.